These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8097953)

  • 21. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contrasting effects of cyclic AMP increase caused by beta-adrenergic stimulation or by adenylate cyclase activation on ventricular fibrillation threshold of isolated rat heart.
    Worthington MG; Opie LH
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):595-600. PubMed ID: 1280716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
    Belhassen L; Kelly RA; Smith TW; Balligand JL
    J Clin Invest; 1996 Apr; 97(8):1908-15. PubMed ID: 8621775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiotonic and coronary vasodilator responses to milrinone, forskolin, and analog P87-7692 in the anesthetized dog.
    Lebedinsky Y; Nordstrom ST; Aschoff SE; Kapples JF; O'Malley GJ; Kosley RW; Fielding S; Hubbard JW
    J Cardiovasc Pharmacol; 1992 May; 19(5):779-89. PubMed ID: 1381777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cyclic nucleotides in heart metabolism.
    Opie LH
    Cardiovasc Res; 1982 Sep; 16(9):483-507. PubMed ID: 6293708
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-adrenergic signal transduction and contractility in the canine heart after cardiopulmonary bypass.
    Dupuis JY; Li K; Calderone A; Gosselin H; Yang XP; Anand-Srivastava MB; Teijeira J; Rouleau JL
    Cardiovasc Res; 1997 Nov; 36(2):223-35. PubMed ID: 9463634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N; Blinks JR
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
    Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
    Chiu WC; Kedem J; Weiss HR; Tse J; Cheinberg BV; Scholz PM
    Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
    Curtis MJ; Garlick PB; Ridley PD
    J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of milrinone and OPC 3911 with those of isoprenaline, forskolin and dibutyryl-cAMP in rat aorta.
    Lindgren S; Andersson KE
    Gen Pharmacol; 1991; 22(4):617-24. PubMed ID: 1718812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative cardiac effects of milrinone and sodium nitroprusside in conscious rats.
    Desjardins S; Cauchy MJ
    Drug Chem Toxicol; 1995 Feb; 18(1):43-59. PubMed ID: 7768199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
    Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
    Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline.
    Belvisi MG; Patel HJ; Takahashi T; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1996 Apr; 117(7):1413-20. PubMed ID: 8730733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relaxant effects of the selective phosphodiesterase inhibitors milrinone and OPC 3911 on isolated human mesenteric vessels.
    Lindgren S; Andersson KE; Belfrage P; Degerman E; Manganiello VC
    Pharmacol Toxicol; 1989 May; 64(5):440-5. PubMed ID: 2549528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrepancy between inotropic response and cyclic AMP production induced by isoprenaline and forskolin in rat ventricle strips.
    Martinez E; Fuentes T; Collado MC; Hernández J
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):157-67. PubMed ID: 9226750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-arrhythmic action of adenosine and the cyclic nucleotide content of the myocardium of rats with ischemia].
    Eliseev VV; Poltavchenko GM; Evdokimova NR; Sokolova EN; Ovchinnikova AG
    Biull Eksp Biol Med; 1987 Jul; 104(7):43-5. PubMed ID: 3040145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A; Martin V; Lugnier C
    Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
    Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.